Effectiveness and timing of vaccination during school measles outbreak

Emerging Infectious Diseases

Volumn 18, Issue 9, 2012, Pages 1405-1413

  Marinovíc, Axel Antonio Bonačić ^a,b   Swaan, Corien ^a   Wichmann, Ole ^c   van Steenbergen, Jim ^a,d   Kretzschmar, Mirjam ^a,b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ROBERT KOCH INSTITUTE   (Germany)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ARTICLE; CALIBRATION; DISEASE TRANSMISSION; DRUG EFFICACY; EPIDEMIC; GERMANY; MEASLES; MEASLES VACCINATION; MEDICAL HISTORY; PATIENT CARE; SCHOOL; STOCHASTIC MODEL;

EID: 84865332374     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1809.111578     Document Type: Article

References (32)

1. Anderson RM, May RM. Vaccination and herd immunity to infectious diseases. Nature. 1985;318:323-329. http://dx.doi. org/10.1038/318323a0
2. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. New York: Oxford University Press; 1991. p. 70.
3. Mossong J, Muller CP. Estimation of the basic reproduction number of measles during an outbreak in a partially vaccinated population. Epidemiol Infect. 2000;124:273-278. http://dx.doi.org/10.1017/ S0950268899003672
4. Wallinga J, Lévy-Bruhl D, Gay NJ, Wachmann CH. Estimation of measles reproduction ratios and prospects for elimination of measles by vaccination in some western European countries. Epidemiol Infect. 2001;127:281-295. http://dx.doi.org/10.1017/ S095026880100601X
5. van Boven M, Kretzschmar M, Wallinga J, O'Neill PD, Wichmann O, Hahné S. Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population. J R Soc Interface. 2010;7:1537-1544. http://dx.doi.org/10.1098/rsif.2010.0086
6. van den Ent MM, Brown DW, Hoekstra EJ, Christie A, Cochi SL. Measles mortality reduction contributes substantially to reduction of all cause mortality among children less than five years of age, 1990-2008. J Infect Dis. 2011;204(Suppl 1):S18-S23. http://dx.doi. org/10.1093/infdis/jir081
7. World Health Organization. Weekly Epidemiological Record. 2002 Feb 15; 77, 7 [cited 2012 Apr 23]. http://www.who.int/wer/2002/ wer7707/en/index.html
8. European Center for Disease Prevention and Control.European monthly measles monitoring, March 2012. Surveillance reports; 2012 Mar 19 [cited 2010 Apr 23]. http://ecdc.europa. eu/en/publications/Publications/Forms/ECDC_DispForm. aspx?ID=843&MasterPage=1
9. Steffens I, Martin R, Lopalco P. Spotlight on measles 2010: measles elimination in Europe-a new commitment to meet the goal by 2015. Euro Surveill. 2010;15:50.
10. Aylward RB, Clements J, Olivé JM. The impact of immunization control activities on measles outbreaks in middle and low income countries. Int J Epidemiol. 1997;26:662-669. http://dx.doi. org/10.1093/ije/26.3.662
11. Grenfell BT, Bjørnstad ON, Kappey J. Travelling waves and spatial hierarchies in measles epidemics. Nature. 2001;414:716-723. http:// dx.doi.org/10.1038/414716a
12. Strebel PM, Cochi SL. Waving goodbye to measles. Nature. 2001;414:695-696. http://dx.doi.org/10.1038/414695a
13. Broutin H, Mantilla-Beniers NB, Simondon F, Aaby P, Grenfell BT, Guégan J-F, et al. Epidemiological impact of vaccination on the dynamics of two childhood diseases in rural Senegal. Microbes Infect. 2005;7:593-599. http://dx.doi.org/10.1016/j.micinf.2004.12.018
14. Grais RF, DE Radiguès X, Dubray C, Fermon F, Guerin PJ. Exploring the time to intervene with a reactive mass vaccination campaign in measles epidemics. Epidemiol Infect. 2006;134:845-849. http:// dx.doi.org/10.1017/S0950268805005716
15. Grais RF, Ferrari MJ, Dubray C, Bjørnstad ON, Grenfell BT, Djibo A, et al. Estimating transmission intensity for a measles epidemic in Niamey, Niger: lessons for intervention. Trans R Soc Trop Med Hyg. 2006;100:867-873. http://dx.doi.org/10.1016/j.trstmh.2005.10.014
16. Grais RF, Conlan AJK, Ferrari MJ, Djibo A, Le Menach A, Bjørn-stad ON, et al. Time is of the essence: exploring a measles outbreak response vaccination in Niamey, Niger. J R Soc Interface. 2008;5:67-74. http://dx.doi.org/10.1098/rsif.2007.1038
17. Alberti KP, King LA, Burny M-E, Ilunga BK, Grais RF. Reactive vaccination as an effective tool for measles outbreak control in measles mortality reduction settings, Democratic Republic of Congo, 2005-2006. In Health. 2010;2:65-68. http://dx.doi.org/10.1016/j. inhe.2009.12.009
18. World Health Organizaion. Response to measles outbreaks in measles mortality reduction settings. Immunization, Vaccines and Bio-logicals; 2009 [cited 2012 Apr 23]. http://www.who.int/immuniza-tion/documents/diseases/measles_who_ivb_09_03/en/index.html
19. Wichmann O, Siedler A, Sagebiel D, Hellenbrand W, Santibanez S, Mankertz A, et al. Further efforts needed to achieve measles elimination in Germany: results of an outbreak investigation. Bull World Health Organ. 2009;87:108-115. http://dx.doi.org/10.2471/ BLT.07.050187
20. Bätzing-Feigenbaum J, Pruckner U, Beyer A, Sinn G, Dinter A, Mankertz A, et al. Spotlight on measles 2010: preliminary report of an ongoing measles outbreak in a subpopulation with low vaccination coverage in Berlin, Germany, January-March 2010. Euro Surveill. 2010;15:13:pii:19527.
21. Richardson M, Elliman D, Maguire H, Simpson J, Nicoll A. Evidence base of incubation periods, periods of infectiousness and exclusion policies for the control of communicable diseases in schools and preschools. Pediatr Infect Dis J. 2001;20:380-391. http://dx.doi. org/10.1097/00006454-200104000-00004
22. Heymann DL. Control of communicable diseases manual. Washington (DC): American Public Health Association; 2008. p. 349.
23. LCI Measles, October 2010. In: Steenbergen JE van, Timen A, Beaujean DJMA, editor. LCI-guidelines infectious disease control edition 2011. Bilthoven (the Netherlands): LCI, Coordinator Infectious Disease Netherlands, 2011. P. 382-392.
24. Helfand RF, Kebede S, Gary HE Jr, Beyene H, Bellini WJ. Timing of development of measles-specifi c immunoglobulin M and G after primary measles vaccination. Clin Diagn Lab Immunol. 1999;6:178-180.
25. Mikolajczyk RT, Akmatov MK, Rastin S, Kretzschmar M. Social contacts of school children and the transmission of respiratory-spread pathogens. Epidemiol Infect. 2008;136:813-822. http://dx.doi. org/10.1017/S0950268807009181
26. Uzicanin A, Zimmerman L. Field effectiveness of live attenuated measles-containing vaccines: a review of published literature. J Infect Dis. 2011;204(Suppl 1):S133-S148. http://dx.doi.org/10.1093/ infdis/jir102
27. Wichmann O, Hellenbrand W, Sagebiel D, Santibanez S, Ahle-meyer G, Vogt G, et al. Large measles outbreak at a German public school, 2006. Pediatr Infect Dis J. 2007;26:782-786. http://dx.doi. org/10.1097/INF.0b013e318060aca1
28. Bailey NTJ. The total size of a general stochastic epidemic. Biometrika. 1953;40:177-185. doi: http://dx.doi.org/10.1093/biom-et/40.1-2.177
29. Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005;438:355-359. http://dx.doi.org/10.1038/nature04153
30. Sakuta H, Sawada S, Kuroki Y. Severity of measles among patients with incidental postexposure vaccination. Jpn J Infect Dis. 2008;61:304-306.
31. Schmid D, Holzmann H, Schwarz K, Kasper S, Kuo H-W, Ab-erle SW, et al. Measles outbreak linked to a minority group in Austria, 2008. Epidemiol Infect. 2010;138:415-425. http://dx.doi. org/10.1017/S0950268809990604
32. Wadl M, Siedler A, Krämer W, Haindl ME, Gebrande S, Krenn-Lan-zl I, et al. Measles transmission from an anthroposophic community to the general population, Germany 2008. BMC Public Health. 2011;11:474. http://dx.doi.org/10.1186/1471-2458-11-474